Matches in Wikidata for { <http://www.wikidata.org/entity/Q73922473> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q73922473 description "artículu científicu espublizáu en xunu de 2000" @default.
- Q73922473 description "im Juni 2000 veröffentlichter wissenschaftlicher Artikel" @default.
- Q73922473 description "scientific article published on 01 June 2000" @default.
- Q73922473 description "wetenschappelijk artikel" @default.
- Q73922473 description "наукова стаття, опублікована в червні 2000" @default.
- Q73922473 name "Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes" @default.
- Q73922473 name "Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes" @default.
- Q73922473 type Item @default.
- Q73922473 label "Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes" @default.
- Q73922473 label "Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes" @default.
- Q73922473 prefLabel "Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes" @default.
- Q73922473 prefLabel "Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes" @default.
- Q73922473 P1433 Q73922473-33F61B9D-7AEA-4DAB-A5C9-A65161427ADA @default.
- Q73922473 P1476 Q73922473-1030C194-58BC-4A35-BC60-155C39ED404C @default.
- Q73922473 P2093 Q73922473-A4A18FD3-11E7-420E-B3FC-48A02D90D863 @default.
- Q73922473 P2093 Q73922473-A9138841-B11E-440D-A03B-66611F102F28 @default.
- Q73922473 P2093 Q73922473-C661EF7A-023A-499F-8BD5-D7BEFF1F8376 @default.
- Q73922473 P2093 Q73922473-F7CF1A36-5AC9-45E1-997E-0A8DA8E4F1CB @default.
- Q73922473 P304 Q73922473-9F547E05-B997-4FF2-8BA4-059F77993641 @default.
- Q73922473 P31 Q73922473-02FEE73D-F55C-4A31-A726-A51CA7660B90 @default.
- Q73922473 P356 Q73922473-00FA54E6-7999-4F44-922D-0A33EFA16B25 @default.
- Q73922473 P407 Q73922473-536B3E18-8C3D-4945-8E6C-FAEA7396A10C @default.
- Q73922473 P433 Q73922473-4E4C765E-2F8E-4A5B-A944-92719C0D31B2 @default.
- Q73922473 P478 Q73922473-7C6416E2-0F97-4B77-97E9-224A3756A547 @default.
- Q73922473 P577 Q73922473-1C3848AB-36A6-4B79-9068-3601574ED409 @default.
- Q73922473 P698 Q73922473-9F5AFF81-9533-48B0-9047-3F34622C2F25 @default.
- Q73922473 P921 Q73922473-73BB1BA1-5397-4686-81FD-E61550F519D8 @default.
- Q73922473 P356 DIABETES.49.6.1033 @default.
- Q73922473 P698 10866057 @default.
- Q73922473 P1433 Q895262 @default.
- Q73922473 P1476 "Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes" @default.
- Q73922473 P2093 "G T Virella" @default.
- Q73922473 P2093 "M A Mironova" @default.
- Q73922473 P2093 "M F Lopes-Virella" @default.
- Q73922473 P2093 "R L Klein" @default.
- Q73922473 P304 "1033-1041" @default.
- Q73922473 P31 Q13442814 @default.
- Q73922473 P356 "10.2337/DIABETES.49.6.1033" @default.
- Q73922473 P407 Q1860 @default.
- Q73922473 P433 "6" @default.
- Q73922473 P478 "49" @default.
- Q73922473 P577 "2000-06-01T00:00:00Z" @default.
- Q73922473 P698 "10866057" @default.
- Q73922473 P921 Q3025883 @default.